Fig. 3: A circular plot showing nine druggable risk genes potentially targeted by 125 drugs either approved or undergoing clinical trials for treatment of CRC. | Nature Communications

Fig. 3: A circular plot showing nine druggable risk genes potentially targeted by 125 drugs either approved or undergoing clinical trials for treatment of CRC.

From: Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility

Fig. 3: A circular plot showing nine druggable risk genes potentially targeted by 125 drugs either approved or undergoing clinical trials for treatment of CRC.The alternative text for this image may have been generated using AI.

The innermost to outermost layers represent CRC, the identified druggable risk genes, and therapeutic drugs - approved (green) or currently under clinical trials (Phase 3: yellow, Phase 2: red).

Back to article page